Global expert services and consulting firm Berkeley Research Group (BRG) has announced that John Barkett has joined the firm as a Washington, DC-based managing director in its Health Care Transactions and Strategy practice. Most recently, he served in the Biden administration as Senior Policy Advisor for Health Care Delivery System Reform at the White House Domestic Policy Council, where he was instrumental in the design of new drug-pricing policies enacted by Congress in 2022 as well as reform of Medicare Advantage, Part D and other Medicare payment policies.
At BRG, Barkett will assume a senior role in a team that advises health plans, health care providers, life sciences companies and health care investors on a range of issues including analysis and development of public policy, corporate strategy and M&A transactions. He will have a particular focus on expanding BRG's public policy capabilities.
"The breadth and depth of John's expertise in this sector—not to mention his prolific DC experience—will be an invaluable asset to BRG clients operating in any number of areas in the health care industry," said Tri MacDonald, BRG's principal executive officer and president. "As regulatory shifts continue to ratchet up the pressure on deals in this space, our clients will take comfort knowing a public-policy expert like John is in their corner."
